SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lemoine Natalie B.

(Last)

(First)

(Middle)

503 KALISTE SALOOM ROAD

(Street)

LAFAYETTE

70508

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/15/2024

3. Issuer Name and Ticker or Trading Symbol
HOME BANCORP, INC. [ HBCP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEVP, Chief Admin. Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,923	D⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾⁽⁵⁾
Common Stock	1,265.9096	I	ESOP

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽⁶⁾	01/12/2026	Common Stock	1,000	$26.81	D
Employee Stock Option (Right to Buy)	⁽⁷⁾	05/23/2026	Common Stock	500	$28	D
Employee Stock Option (Right to Buy)	⁽⁸⁾	05/12/2027	Common Stock	400	$35.26	D
Employee Stock Option (Right to Buy)	⁽⁹⁾	05/23/2028	Common Stock	500	$45.12	D
Employee Stock Option (Right to Buy)	⁽¹⁰⁾	05/23/2029	Common Stock	500	$35.85	D
Employee Stock Option (Right to Buy)	⁽¹¹⁾	03/12/2030	Common Stock	500	$21.99	D
Employee Stock Option (Right to Buy)	⁽¹²⁾	05/12/2031	Common Stock	500	$36.77	D

Explanation of Responses:

1. Includes the grant of 1250 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock.

2. Includes the grant of 250 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on March 12, 2021, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 50 restricted stock units remain unvested.

3. Includes the grant of 250 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 100 restricted stock units remain unvested.

4. Includes the grant of 750 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 450 restricted stock units remain unvested.

5. Includes the grant of 800 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 640 restricted stock units remain unvested.

6. The options vest and become exercisable in five equal installments beginning January 12, 2017

7. The options vest and become exercisable in five equal installments beginning May 23, 2017

8. The options vest and become exercisable in five equal installments beginning May 12, 2018.

9. The options vest and become exercisable in five equal installments beginning May 23, 2019.

10. The options vest and become exercisable in five equal installments beginning May 23, 2020

11. The options vest and become exercisable in five equal installments beginning March 12, 2021.

12. The options vest and become exercisable in five equal installments beginning May 12, 2022.

	/s/ Natalie B. Lemoine	07/24/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.